Results 231 to 240 of about 14,994,869 (262)

Comparison of clinical practice guidelines for chronic hepatitis B: natural history classification and treatment initiation. [PDF]

Clin Mol Hepatol
Kim GA, Choi WM, Choi GH, Kim IH, Kanto T, Yu ML, Lim YS.   +6 more
europepmc   +1 more source

Letter to the Editor: Physical functioning as a neglected determinant of antiviral adherence in chronic hepatitis B. [PDF]

World J Virol
Huang XF, Zeng JQ.
europepmc   +1 more source

Impact of Switching from Tenofovir Disoproxil Fumarate to Tenofovir Alafenamide or Entecavir in Older Patients with Chronic Hepatitis B. [PDF]

Infect Dis Ther
Cesanelli F, Nozza O, Gottardi F, Mosti F, Zaltron S, Tiecco G, Scarvaglieri I, Spinetti A, Castelli F, Quiros-Roldan E.   +9 more
europepmc   +1 more source

Chronic hepatitis B and perioperative chemotherapy efficacy in colorectal liver metastases: an exploratory analysis of clinical and mechanistic evidence. [PDF]

Front Immunol
Cheng CL, Tong SY, Mo SB, Cai SJ, Peng JJ, Hu X.   +5 more
europepmc   +1 more source

HBsAg glycan isomer: a potential circulating biomarker for monitoring cccDNA and predicting virologic response in chronic hepatitis B. [PDF]

Front Cell Infect Microbiol
Li J, Hu Z, Wu M, Ji Y, Zhang X, Chen F, Wu X, Zhang Q, Chen C, Zhu C, Zhu L.   +10 more
europepmc   +1 more source

Lower MACE but higher mortality in chronic hepatitis B infection: A competing risk explanation? [PDF]

Int J Cardiol Cardiovasc Risk Prev
Hou R, Chen T.
europepmc   +1 more source